Biotech VCs ramp up checks on new bets after years of focusing on existing portfolios
在多年专注现有投资组合后，生物科技风投加紧审查新下注

Biotech venture capitalists are embracing risk again, signaling a reversal from the past few years.
生物科技风投再次拥抱风险，显示出与过去几年的情况相反的回归迹象。